PXT00864

DRUG2 trials

Sponsors

Pharnext S.C.A.

Conditions

Alzheimer Disease

Phase 2

Pilot Study Assessing the Effects of PXT00864 in Patients With Mild Alzheimer Disease (AD)

CompletedNCT02361424

Pharnext S.C.A.Alzheimer Disease

Start: 2013-02-28End: 2015-06-30Updated: 2016-02-15

24-week Open-label Extension Study Evaluating PXT00864 Effect in Mild AD Patients Further to PLEODIAL-I Completion

CompletedNCT02361242

Pharnext S.C.A.Alzheimer Disease

Start: 2013-06-30End: 2015-12-31Updated: 2016-02-15